Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Pilot trial finds XOMA-052 beneficial in uveitis of Behcet's disease

June 29, 2010

Interim phase II data reported on ENB-0040 in childhood hypophosphatasia

June 29, 2010

Pooled phase III data show efficacy of tesamorelin in HIV-related lipodystrophy

June 29, 2010

SB-1518 dose selected for phase II evaluation in myelofibrosis

June 29, 2010

Phase III data released on tanezumab in knee osteoarthritis pain

June 29, 2010

Pardoprunox is effective in PD but dose adjustment is needed

June 28, 2010

Phase III data detailed for add-on safinamide in PD

June 28, 2010

First-in-human data presented on MLN-9708 in nonhematologic cancer

June 28, 2010

RAD-1901 is efficacious in phase IIa trial in postmenopausal women

June 28, 2010

GDNF gene therapy shows promise in Parkinson's disease model

June 28, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 26, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 27, 2026.
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Muted and missing M&As: JPM deals absent in 2026
BioWorld
For years, the J.P. Morgan Healthcare Conference (JPM) kicked off with splashy headlines of major M&A activity among biopharma companies, but in 2026, the hype...
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...